USANA Health Sciences Revenue 2011-2026 | USNA

Company revenue is the total amount of money received from the sale of goods or services over a certain period of time. It is one of the key indicators of a company's financial condition and success.

Traditionally defined as follows:
Revenue = Price * Quantity of products

Revenue is one of the components of a company’s income. In international practice, revenue is understood as the inflow or other increase in a company's assets or the settlement of its obligations that occurs as a result of the company’s core or main activity.^[1]

This is an important indicator for assessing the financial condition and efficiency of a company. It makes it possible to determine how successfully a company sells its products or services on the market. In addition, revenue can be used to calculate other financial indicators such as profit, profitability, and market share.

Various factors can influence this indicator, including demand for goods or services, market competition, economic conditions, and the company's marketing efforts. Therefore, its analysis and monitoring are important tasks for the successful development of a business.

Annual Revenue USANA Health Sciences

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
921 M	999 M	1.13 B	-	1.06 B	1.19 B	1.05 B	918 M	790 M	-	718 M	649 M	518 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
1.19 B	518 M	904 M

Quarterly Revenue USANA Health Sciences

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
214 M	236 M	250 M	-	200 M	213 M	228 M	-	213 M	238 M	248 M	-	233 M	264 M	273 M	-	274 M	337 M	308 M	-	299 M	259 M	267 M	271 M	261 M	256 M	273 M	299 M	297 M	301 M	292 M	273 M	262 M	257 M	255 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
337 M	200 M	262 M

References

Adhikari, B. (2010). Impact of Revenue Planning In Nepal Investment Bank Limited (Doctoral dissertation, Faculty of Management).

Revenue of other stocks in the Household products industry

Issuer	Revenue	Price	% 24h	Market Cap	Country
Natura &Co Holding S.A. NTCO	26.7 B	-	-	$ 9.02 B	-
The Clorox Company CLX	7.1 B	$ 118.97	-1.8 %	$ 14.7 B	USA
Colgate-Palmolive Company CL	20.4 B	$ 95.21	-0.3 %	$ 77 B	USA
The Estée Lauder Companies EL	14.3 B	$ 99.28	0.57 %	$ 35.8 B	USA
Coty COTY	5.89 B	$ 2.43	-1.02 %	$ 2.12 B	USA
Dogness (International) Corporation DOGZ	27.1 M	$ 1.5	2.04 %	$ 50.6 M	China
Acme United Corporation ACU	194 M	$ 44.08	-0.61 %	$ 163 M	USA
Helen of Troy Limited HELE	1.91 B	$ 16.7	-1.36 %	$ 384 M	Bermuda
e.l.f. Beauty ELF	321 M	$ 81.0	-0.07 %	$ 4.43 B	USA
Revlon REV	2.08 B	-	-4.41 %	$ 212 M	USA
Church & Dwight Co. CHD	6.2 B	$ 102.33	-0.66 %	$ 24.8 B	USA
Inter Parfums IPAR	1.32 B	$ 93.64	-1.95 %	$ 3 B	USA
Kimberly-Clark Corporation KMB	4.08 B	$ 103.94	-0.67 %	$ 34.5 B	USA
LifeVantage Corporation LFVN	229 M	$ 4.83	0.57 %	$ 59.2 M	USA
Mannatech, Incorporated MTEX	132 M	$ 6.73	-	$ 12.6 M	USA
Nu Skin Enterprises NUS	1.73 B	$ 7.48	-0.93 %	$ 369 M	USA
Newell Brands NWL	7.2 B	$ 4.42	1.14 %	$ 1.85 B	USA
Edgewell Personal Care Company EPC	2.25 B	$ 21.22	-0.89 %	$ 1.05 B	USA
Hims & Hers Health HIMS	2.35 B	$ 15.91	0.57 %	$ 3.58 B	USA
United-Guardian UG	10.9 M	$ 6.59	-	$ 30.3 M	USA
Unilever PLC UL	60.8 B	$ 68.76	-0.56 %	$ 132 B	Britain
Nature's Sunshine Products NATR	445 M	$ 27.11	0.48 %	$ 517 M	USA
The Procter & Gamble Company PG	84.3 B	$ 158.2	-0.98 %	$ 372 B	USA
Spectrum Brands Holdings SPB	2.81 B	$ 78.03	0.25 %	$ 2.01 B	USA